Cell signaling research requires targeted and reliable approaches to connect changes in gene expression with biological pathways. AnyGenes develops pathway-focused qPCR arrays, validated primers, reverse transcription and amplification reagents, and dedicated analysis tools for researchers studying signaling pathways, biomarkers and disease-associated transcriptional responses.
From ready-to-use SignArrays® to customized qPCR panels, our solutions can support standard workflows as well as projects involving low-input or challenging RNA samples.
SignArrays® pathway panels are evaluated using stringent quality-control criteria to support reliable pathway-focused gene expression analysis.
Choose from a broad catalog of ready-to-use panels or develop personalized SignArrays® based on your genes, pathway, species and research objective.
Primer designs target exon-spanning regions whenever applicable to help reduce amplification from contaminating genomic DNA.
Combine SignArrays® with validated primers, reverse transcription, pre-amplification, compatible Master Mixes and dedicated analysis tools.
AnyGenes supports researchers from panel selection and assay design to targeted biomarker validation and data interpretation.
Dedicated analysis tools are available for SignArrays® to support structured qPCR data interpretation, from normalization to comparison of experimental conditions and graphical visualization.
AnyGenes technologies have been used in peer-reviewed research across cancer biology, cardiovascular and pulmonary research, transcriptomics and biomarker studies. Selected examples below illustrate how SignArrays®, custom qPCR panels and complementary gene expression solutions have been integrated into independent research workflows.
2026 – lncRNA profiling and methotrexate resistance
Delgado A. et al. – Biochemical Pharmacology
A study investigating the transition from early methotrexate response to resistance in HT29 colorectal cancer cells used the AnyGenes Human LncRNA and Cancer SignArray® LNCC1H1 together with StaRT reverse transcription and SignArray® data analysis tools.
AnyGenes technologies:
Human LncRNA and Cancer SignArray® LNCC1H1; StaRT Reverse Transcription Kit; SignArray® analysis software
2025 – Endothelial dysfunction in pulmonary arterial hypertension
Saint-Martin Willer A. et al. – Respiratory Research
Research on pulmonary arterial hypertension used targeted AnyGenes qPCR solutions to investigate endothelial dysfunction and vascular gene expression.
AnyGenes technologies:
Endothelial Dysfunction SignArray®; StaRT Reverse Transcription Kit; Perfect Master Mix SYBR® Green with ROX
2021 – Transcriptomic alterations in Cornelia de Lange syndrome
Garcia P. et al. – Nature Communications
Transcriptomic alterations associated with Cornelia de Lange syndrome were investigated, with selected gene expression findings assessed using customized AnyGenes qPCR panels.
AnyGenes technology:
Custom gene expression qPCR panels
AnyGenes technologies have also been reported in studies published in journals including Cancer Research, Circulation, Redox Biology, Cancer Letters and PLOS ONE.
Build a targeted gene expression workflow using pathway-focused qPCR arrays, validated assays and complementary molecular tools adapted to your research question and sample requirements.
Analyze selected genes involved in signaling pathways, biological processes and disease-associated transcriptional signatures using ready-to-use or customized qPCR panels.
Key features:
Perfect Master Mix formulations designed to support reliable amplification across gene expression and SignArrays® workflows.
Key features:
FEATURED
Pre-amplification solutions designed for projects where RNA quantity is limited or target transcripts are present at low abundance.
Key features:
Experimentally validated primer sets for targeted gene expression analysis across genes, pathways and research species.
Key features:
Targeted qPCR solutions for quantifying long non-coding RNAs identified through RNA-seq, literature review or disease-focused research.
Key features:
FEATURED
Targeted qPCR solutions for analyzing selected microbial signatures in research applications.
Key features:
PCR- and qPCR-based solutions designed to support routine detection of mycoplasma contamination in research cell cultures.
Key features:
Scientific support for biomarker identification, targeted gene expression analysis, qPCR validation and customized molecular workflows.
Key features:
Personalized SignArrays® can be designed using your selected genes, signaling pathway, species and experimental requirements. Custom panels can support disease-focused signatures, biomarker validation, RNA-seq follow-up and targeted pathway analysis.
Request a personalized SignArray®Study gene expression patterns associated with tumor biology, proliferation, survival and cell death.
Analyze transcriptional signatures associated with cytokine signaling, innate immunity and inflammatory pathways.
Investigate pathway-related gene expression in vascular, cardiac and pulmonary research models.
Explore gene expression responses associated with oxidative stress, neuroinflammation and cell survival.
Confirm selected transcriptomic findings using targeted qPCR assays or pathway-focused panels.
Researchers use AnyGenes solutions for customized qPCR arrays, signaling pathway analysis, neural cell models, biomarker research and cell culture quality control.
INSERM
“The customized SignArrays® developed by AnyGenes® were pivotal in conducting critical analyses published in high-impact journals.”
INSERM
“The customized SignArrays® developed by AnyGenes® played a crucial role in analyzing 2D and 3D neural cells derived from patients with neurodevelopmental disorders.”
AP-HP
“We are very satisfied with the quality of the reagent, the delivery times and the response time of the AnyGenes® team.”
1- FORUM LABO PARIS 28-30 MARCH 2023
Please join us at our booth #H105, hall H, to learn more about AnyGenes’s products and molecular services
2- 7th Drug Discovery Summit, 2022-Madrid
AnyGenes will participate to the 7th Drug Discovery Summit, 2022-Madrid. Dr NAIMI, will give a talk on the importance of signaling pathways and biomarkers in the process of drug development, by using AnyGenes molecular platform
3- Importation of biological samples
AnyGenes obtained from The Ministry of Agricultural the authorisation to import biological samples from outside the European Union
4- Distribution agreement with Hölzel Diagnostika
We welcome Hölzel Diagnostika Handels GmbH as new distributor of AnyGenes products and services in Germany, Austria and Switzerland
5- BIO-Europe Spring 2020
AnyGenes will be present at BIO-Europe Spring 2020
6- AnyGenes products and services in JAPAN
We are proud to have signed an agreement with the company Funakoshi, Co, Ltd, for the distribution of AnyGenes products and services in JAPAN
7- BIOFIT 2018, LILLE, 4-5 December
AnyGenes team will be present at BioFIT Event 2018 at Lille, FRANCE
8- Specific Pre-amplification kit
You have small quantity of biological sample but many signaling pathways to explore? AnyGenes® team is proud to help you with our new range of cDNA pre-amplification SpeAmpn system to perform high-throughput analysis with very small amounts of biological material (5 ng RNA) or few cells.
9- MEDICA 2017/ Dûsseldorf, GERMANY, 13-16 NOV
AnyGenes® team was present at MEDICA 2017, the key world forum for medicine. AnyGenes® stays informed of all the news, innovative projects, latest technologies and issues in medical fields in order to offer you innovative products and tools.
10- BioJapan/ Regenerative Medicine Japan 2016
AnyGenes® has been selected by the EU-Japan centre, for BtoB meetings at Osaka from 9-11 October, and to present its products (SignArrays®) and its multi-biomarkers clinical tests at BioJapan 2016, October 12-14, Yokohama, JAPAN.
11- Chinese Medicine Conference 2016
Dr Ju Liya has held a conference at the 2nd World Forum on Astragalus membranaceus, 10 June 2016 at Beijing CHINA. Dr Ju Liya had talked about interesting results from in vitro analysis of compounds from chinese medicine by using AnyGenes® molecular platform.
12- Products
Discover now our various signaling pathways (SignArrays®) and Highly sensitive and specific assay kits for specific gene quantification by real time qPCR array.
Whether you are studying signaling pathways, validating RNA-seq findings, analyzing low-input samples or developing a targeted biomarker panel, our scientific team can help you identify an appropriate qPCR strategy for your research objectives.
